NovoCure Ltd (NVCR):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:NovoCure Ltd (NVCR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7214
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer and small cell lung cancer, among others. It also offers provides products for other indications such as glioblastoma and diagnosed glioblastoma, among others. Novocure owns and operates a research centre in Haifa, Israel; and operates along with its subsidiaries located in the US; Berlin, and Germany. The company has its operations in Japan and Switzerland. NovoCure is headquartered in St. Helier, the UK.

NovoCure Ltd (NVCR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NovoCure Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
NovoCure Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
NovoCure Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
NovoCure Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
NovoCure Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
NovoCure Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
NovoCure Secures USD25 Million from Pharmakon 10
Zai Lab Enters into Licensing Agreement with Novocure 11
Equity Offering 13
NovoCure Announces Partial Exercise of Underwriter’s Option for IPO for USD173.3 Million 13
NovoCure Raises USD95 Million in Public Offering of Series J Shares 15
NovoCure Raises USD194 Million in Public Offering of Series I Shares 16
NovoCure Raises USD55 Million in Public Offering of Series H Shares 17
NovoCure Ltd – Key Competitors 18
NovoCure Ltd – Key Employees 19
NovoCure Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Apr 26, 2018: Novocure Reports First Quarter 2018 Financial Results and Provides Company Update 21
Feb 22, 2018: Novocure Announces Fourth Quarter and Full Year 2017 Financial Results 23
Jan 09, 2018: Novocure Announces Fourth Quarter and Full Year 2017 Operating Statistics and Preliminary Revenue 26
Oct 26, 2017: Novocure Reports Third Quarter 2017 Financial Results and Provides Company Update 27
Jul 27, 2017: Novocure Reports Second Quarter 2017 Financial Results and Provides Company Update 30
Apr 27, 2017: Novocure Reports First Quarter 2017 Financial Results and Provides Company Update 33
Corporate Communications 35
Aug 02, 2018: Novocure announces addition to its Board of Directors 35
May 31, 2018: Novocure Announces Changes to Its Board of Directors 36
Feb 07, 2018: Novocure Secures New $150 Million Non-Dilutive Term Loan Financing 37
May 11, 2017: Martin J. Madden Joins Novocure Board of Directors 38
Product News 39
Apr 13, 2018: Data on Tumor Treating Fields to Be Presented at American Association for Cancer Research Annual Meeting 39
Mar 15, 2018: Novocure Announces 35 Presentations on Tumor Treating Fields at the American Association for Cancer Research Annual Meeting 2018 40
Nov 08, 2017: Novocure Announces 13 Preclinical Presentations Highlighting Data on Tumor Treating Fields’ Mechanism of Action at 22nd Annual Meeting of the Society for Neuro-Oncology 43
Sep 06, 2017: Novocure Announces Data Presentations at the ESMO 2017 Congress 45
Jul 11, 2017: Data on Delivery of Tumor Treating Fields to be Presented at the 39th Annual International Conference of the IEEE Engineering in Medicine and Biology Society 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
NovoCure Ltd, Medical Equipment, Key Facts, 2017 2
NovoCure Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
NovoCure Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
NovoCure Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
NovoCure Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
NovoCure Ltd, Deals By Market, 2012 to YTD 2018 8
NovoCure Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
NovoCure Secures USD25 Million from Pharmakon 10
Zai Lab Enters into Licensing Agreement with Novocure 11
NovoCure Announces Partial Exercise of Underwriter’s Option for IPO for USD173.3 Million 13
NovoCure Raises USD95 Million in Public Offering of Series J Shares 15
NovoCure Raises USD194 Million in Public Offering of Series I Shares 16
NovoCure Raises USD55 Million in Public Offering of Series H Shares 17
NovoCure Ltd, Key Competitors 18
NovoCure Ltd, Key Employees 19
NovoCure Ltd, Subsidiaries 20

List of Figures
NovoCure Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
NovoCure Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
NovoCure Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
NovoCure Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
NovoCure Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
NovoCure Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
NovoCure Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
NovoCure Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[NovoCure Ltd (NVCR):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Laboratorios Liomont SA de CV:製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratorios Liomont SA de CV (Liomont) is a pharmaceutical company that develops medication products. The company offers prescription medication products, biotech products and over the counter products. It provides drugs in various therapeutic areas including analgesics, antiparasitic, anti …
  • Tata Motors Limited:企業の戦略・SWOT・財務分析
    Tata Motors Limited - Strategy, SWOT and Corporate Finance Report Summary Tata Motors Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Raymond Ltd (RAYMOND):企業の財務・戦略的SWOT分析
    Raymond Ltd (RAYMOND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • InTouch Technologies Inc:企業の戦略的SWOT分析
    InTouch Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Transnet SOC Ltd:企業の戦略的SWOT分析
    Transnet SOC Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Coats Group plc:戦略・SWOT・企業財務分析
    Coats Group plc - Strategy, SWOT and Corporate Finance Report Summary Coats Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • CaixaBank SA:企業の戦略・SWOT・財務情報
    CaixaBank SA - Strategy, SWOT and Corporate Finance Report Summary CaixaBank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • De Lage Landen International B.V.:企業の戦略・SWOT・財務情報
    De Lage Landen International B.V. - Strategy, SWOT and Corporate Finance Report Summary De Lage Landen International B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Fisher & Paykel Appliances Holdings Limited:企業の戦略的SWOT分析
    Fisher & Paykel Appliances Holdings Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Domain Therapeutics SA-製薬・医療分野:企業M&A・提携分析
    Summary Domain Therapeutics SA (Domain Therapeutics) is a biopharmaceutical company that discovers and develops innovative therapeutics for the treatment of Central Nervous System (CNS) diseases and cancer by using transmembrane and G Protein-Coupled Receptor (GPCR) platform. Its pipeline consists o …
  • Premier Foods plc:企業の戦略・SWOT・財務情報
    Premier Foods plc - Strategy, SWOT and Corporate Finance Report Summary Premier Foods plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • U-Haul International Inc:企業の戦略的SWOT分析
    U-Haul International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Xspray Pharma AB (XSPRAY):製薬・医療:M&Aディール及び事業提携情報
    Summary Xspray Pharma AB (Xspray Pharma), formerly Xspray Microparticles AB, is a drug development company that develops and commercializes protein kinase inhibitors (PKI) for targeted cancer treatments. The company’s drug candidates include HyNap-Dasa, HyNap-Nilo and HyNap-Sora. Its protein kinase …
  • Brunei National Petroleum Co Sdn Bhd:石油・ガス:M&Aディール及び事業提携情報
    Summary Brunei National Petroleum Co Sdn Bhd (PetroleumBRUNEI) is an oil and gas company that provides exploration and production of oil and gas. The company offers engineering, procurement, construction, installation, commissioning services, and others. It provides oilfield services, onshore and of …
  • Samart Corporation Public Co Ltd (SAMART):企業の財務・戦略的SWOT分析
    Samart Corporation Public Co Ltd (SAMART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Australian Broadcasting Corporation:企業の戦略的SWOT分析
    Australian Broadcasting Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Wellington Pub Company PLC:企業の戦略・SWOT・財務情報
    Wellington Pub Company PLC - Strategy, SWOT and Corporate Finance Report Summary Wellington Pub Company PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Enel Americas SA:企業の戦略・SWOT・財務分析
    Enel Americas SA - Strategy, SWOT and Corporate Finance Report Summary Enel Americas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Southern Co (SO):企業の財務・戦略的SWOT分析
    Southern Co (SO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • GS Energy Corp-エネルギー分野:企業M&A・提携分析
    Summary GS Energy Corp (GS Energy) is an energy holding company that manufactures and markets transportation fuels. The company's services include exploration and production, green growth, gas and electric power, refining and petrochemicals. It's refining and petrochemicals services comprise manufac …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆